GUTS earnings date and last-quarter result: last quarter beat, P/E -0.44. Updated 2026-07-23.
Fractyl Health (GUTS) Research Hub
Fractyl Health (GUTS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.07 USD (-0.93%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.44, market cap 0.06B. This hub links to the full technical, earnings and options research available for GUTS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.07 USD (-0.93%) |
| 52-week range | 0.4 USD – 4.81 USD |
| Trend regime | Range |
| 14-day RSI | 7.8 (Oversold) |
| Trailing P/E | -0.44 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
Available research for GUTS
Covered Call on GUTS: how it works, illustrative setup around the real 1.07 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GUTS: how it works, illustrative setup around the real 1.07 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GUTS: how it works, illustrative setup around the real 1.07 USD price, max profit/loss, breakeven and when to use it. Educational.
GUTS technical analysis: range, last 1.07 USD, RSI 7.8, 52w range 0.4 USD–4.81 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is GUTS in?
Fractyl Health (GUTS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is GUTS in an uptrend or downtrend?
As of 2026-10-26, GUTS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GUTS's trailing P/E ratio?
GUTS's trailing P/E is -0.44, with a market cap of 0.06B. See the earnings research page for full valuation detail.